Bio-Me strengthens their team with the hire of a Chief Clinical Officer
Runar Vige has taken on the role of Chief Clinical Officer. Runar brings more than 20 years of broad interdisciplinary experience working with companies like Pfizer, Pronova BioPharma, and BASF. Read More
05 June, 2020
Bio-Me receives 2 million Euro in public funding
Bio-Me has received 2 million Euro in grants and public support from The Research Council of Norway to develop a companion diagnostic test for immune checkpoint inhibitor cancer treatments. Read More
23 April, 2020
Bio-Me part of unique Nordic IBD initiative
Bio-Me is one of the participants in a new Nordic project that will develop personalized treatment for IBD patients.
Read More12 August, 2019
Official Opening of Service Laboratory
Bio-Me, a pioneer in rapid gut microbiome analysis is announcing the opening of its gut microbiome analysis service laboratory.
Read More14 June, 2019
Bio-Me deal with top 10 Consumer Company
Bio-Me has entered into an agreement with one of the top ten consumer healthcare companies worldwide.
Read More19 February, 2019
Bio-Me at 4th National Microbiota Conference
Dr. Morten Isaksen, CEO of Bio-Me, has been invited to present Bio-Me and its contribution to use of information from the gut microbiome in clinical settings.
Read More19 February, 2019
Dr. Morten Isaksen on LØRN podcast
Morten Isaksen, CEO of Bio-Me, is featured on LØRN, leading Norwegian technology blog and podcast service.
Read More07 December, 2018
Bio-Me to receive Aleap Pre-Seed Fund
Bio-Me is pleased to announce that it has been selected as the recipient of Aleap Pre-Seed Fund.
Read More20 November, 2018
Bio-Me takes part in Katapult Accelerator
After a globally competitive process spanning two months, Bio-Me was selected as one of twelve companies to be part of Katapult Accelerator (KA) Batch 3. Read More
28 August, 2018
Bio-Me one of 25 most innovative companies
INNOMAG, the leading innovation magazine in Norway, has selected Bio-Me as one of the 25 most innovative new companies in Norway in 2018. Read More
26 June, 2018
Dr. Morten L. Isaksen speaks at conference
The conference brings together leaders and executives from the pharmaceutical, biotech, academic, and government communities. Read More
09 April, 2018
Norwegian Prime Minister visits Bio-Me
The Prime Minister was very attentive and eager to learn how GutChek(TM) from Bio-Me, combined with information and samples from HUNT can provide better health treatment and preventative measures. Read More
21 March, 2018
Bio-Me at Microbiome R&D Business Forum
Bio-Me will be presenting new results from the development of its proprietary GutCheck(TM) gut microbiome analysis platform Read More
12 March, 2018
Dr. Isaksen speaks at Big Data Conference
On Wednesday 14th February, Tekna, the main national engineering society in Norway, invited its members to an evening regarding the use of Big Data in the Norwegian health innovation system. Read More
14 February, 2018
Bio-Me signs MOU with miniSV, China
Representatives from Bio-Me attended the Grand Opening of MiNiSV at Yangzi Sci-Tech Innovation Centre, Nanjing on Friday October 20th, 2017. Read More
20 October, 2017
Bio-Me & NTNU (HUNT4) sign agreement
In a milestone agreement, Bio-Me and NTNU have signed a Collaboration Agreement, giving Bio-Me access to analyze the approximately 30,000 fecal samples that will be collected as part of the ongoing HUNT 4 study. Read More
03 October, 2017
Bio-Me first tenant at OsloTech’s ShareLab
Bio-Me became the first tenant at ShareLab, the premium laboratory hotel offered by OsloTech as part of Oslo Research Park, close to the University of Oslo and Oslo University Hospital. Read More
02 October, 2017
Bio-Me attends RESI Boston conference
As part of their future plans of expansion into the North American market, Bio-Me will be attending the RESI Boston conference on Monday 25th September 2017. Read More
27 September, 2017
Bio-Me signs a Joint Venture with MiNiSV
In a historic moment, Bio-Me signed an agreement for setting up a Joint Venture and License Agreement with MiNiSV in Nanjing, China. Read More
16 January, 2018
Bio-Me present at Microbiome Invest Forum
At the recent Microbiome Invest Forum in London, organized by Kisaco Research, Bio-Me was invited to present data from their development of GutCheck(TM), the next generation gut microbiome analysis. Read More
31 May, 2017
Bio-Me presentation available online
Morten L. Isaksen, CEO of Bio-Me, was invited to give a presentation on the future of gut microbiome analysis at the recent 4th Microbiome R&D and Business Collaboration Forum in Amsterdam 3 - 4 April 2017. Read More
24 May, 2017
Collaboration agreement with the University of Oslo
Bio-Me and the University of Oslo, Department of Biosciences, Centre for Ecological and Evolutionary Synthesis (CEES) have entered into a collaboration agreement Read More
22 December, 2016
Bio-Me awarded grant from RCN
Bio-Me AS has been awarded a grant under The Programme for Regional R&D and Innovation (VRI) from the Research Council of Norway (RCN) Read More
05 December, 2016
Bio-Me AS presents at DNB NXT Oslo
Bio-Me AS has been selected to present at the Norwegian Investment Forum 2016, organized in partnership with DNB at DNB NXT, as part of Oslo Innovation Week. Read More
14 October, 2016
HRH the Crown Prince opens Aleap
Wednesday 12th October was the official opening of Aleap - the new Health Incubator located at the Oslo Science Park, where Bio-Me AS is located. Read More
13 October, 2016
Norwegian King and Queen watch as Bio-Me presents
As one of only four selected companies, Bio-Me AS will present to investors and angel investors in Helsinki, Finland. Read More
19 August, 2016
Bio-Me AS presents at SeedForum Stockholm
Bio-Me AS will present its business case at the SeedForums investor event hosted by Carnegie Investment Bank in Stockholm 9th September 2016. Read More
21 June, 2016
